Feds Release Startling Data on Hospital-Acquired Infections

Federal data just released demonstrate the dangers of being hospitalized in America.

According to data collated from a 2011 study of 183 U.S. hospitals, the U.S. Centers for Disease Control and Prevention have determined that one in 25 hospital patients in the country will catch a potentially deadly infection while at the hospital.

Along with the methicillin-resistant staph infection Staphylococcus aureus and Clostridium difficile, The Washington Post broke down the infections found to be most common:

  • Pneumonia, 22 percent
  • Surgical site infections, 22 percent
  • Gastrointestinal infections, 17 percent
  • Urinary tract infections, 13 percent
  • Bloodstream infections, 10 percent

"You go to the hospital hoping to get better," said Dr. Micheal Bell of the CDC to NBC News. "Unfortunately that doesn't always happen. Although there has been some progress, today and every day, more than 200 Americans with healthcare-associated infections will die during their hospital stay."

Transmission from the hospital to the patient can occur in a number of ways, but experts believe that the most common culprits are equipment that the hospital has failed to adequately sterilize, health care workers who fail to properly and adequately wash their hands, and the overuse of antibiotics, making them unable to kill bacteria.

Bloodstream infections are a special threat to cancer patients who require a central line, but on that front there is some good news: another CDC report found that such infections are down 44 percent from 2008.

These findings have been reported in the most recent issue of the New England Journal of Medicine.

Source: Digital Journal

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap